On Friday, Ball Corporation BLL explained in an 8-K that the post-Rexam close leverage of 4.5x doesn't include $300 million in synergies. The confusion drove shares lower on Friday and continued Tuesday afternoon, with shares down 1.6 percent at $70.25 on the day.
Jefferies analysts believe this pullback provides a buying opportunity for shareholders for a number of reasons.
Reiterating that Ball is one of the firm's top picks, they believe the 8-K offered more visibility into the "choppy macro backdrop" from Rexam synergies. Jefferies noted that for every 100 basis points greater than 9 percent AT hurdle rate would provide $70 million in earnings before interest & tax. Noting that Ball management is being conservative with guidance, Jefferies believes the 3x leverage target in 2018 by management, would allow the company to revisit a buyback program in late 2017 or early 2018.
Jefferies reiterating their Buy rating and $86 price target.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.